On the other hand, it has been demonstrated mechanistically that when mTOR levels rise in cancer cells, it binds to MondoA directly in the cytoplasm and prevents the formation of the MondoA/Mlx complex which limits MondoA nuclear entry and TXNIP transcription and expression [107]. The gene discussed is MTOR; the disease is cancer.